Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

August 31, 2005

Conditions
Crohn's Disease
Interventions
DRUG

STA-5326 mesylate

Trial Locations (35)

10128

Asher Kornbluth, MD, New York

14607

Rochester Institute for Digestive Diseases and Sciences, Inc., Rochester

15213

University of Pittsburgh, Pittsburgh

20707

Maryland Digestive Disease Research, Laurel

20815

Chevy Chase Clinical Research, Chevy Chase

20901

Capital Gastroenterology Consultants, P.A., Silver Spring

24073

New River Valley Research Institute, Christiansburg

27103

Piedmont Medical Research Associates, Winston-Salem

27612

Wake Research Associates, LLC., Raleigh

28211

Carolina Digestive Health Associates, Charlotte

28374

Pinehurst Medical Clinic, Pinehurst

28801

Asheville Gastroenterology Associates, PA, Asheville

29203

Columbia Gastroenterology Associates, P.A., Columbia

30342

Atlanta Gastroenterology, Atlanta

32204

Borland Groover Clinic, Jacksonville

32789

Shafran Gastroenterology Center, Winter Park

33021

Southern Clinical Research Consultants, Hollywood

33173

Miami Research Associates, Miami

34684

Advanced Gastroenterology Highland Lakes Medical Center, Palm Harbor

37205

Nashville Medical Research Institute, Nashville

38138

Gastroenterology Center of the MidSouth, Germantown

40202

Univ. of Louisville Clinical Research Unit, Louisville

53215

Wisconsin Center for Advanced Research, Milwaukee

63128

St. Louis Center for Clinical Research, St Louis

72205

Gastroenterology Associates, Little Rock

78745

Austin Gastroenterology, Austin

92123

Medical Associates Research Group, San Diego

92801

Advanced Clinical Research Institute, Anaheim

92868

Community Clinical Trials, Orange

02118

Boston Medical Center, Boston

07927

Gastroenterology Research Associates, Cedar Knolls

T2N4N1

University of Calgary Health Sciences, Calgary

N6A 4G5

London Health Science Center South Street Campus, London

N6A 5A5

London Health Science Center University Campus, London

S7K1N4

Saskatoon Medical Specialists, Saskatoon

All Listed Sponsors
lead

Synta Pharmaceuticals Corp.

INDUSTRY

NCT00138840 - Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease | Biotech Hunter | Biotech Hunter